XML 156 R146.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Payment (Details) - Schedule of stock options activity - $ / shares
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Schedule of stock options activity [Abstract]          
Number of Shares, Outstanding at beginning (in Shares) 33,503,657 34,737,967 34,737,967    
Weighted Average Exercise Price, Outstanding at beginning $ 6.19 $ 6.19 $ 6.19    
Weighted Average Grant Date Fair Value, Outstanding at beginning $ 4.95 $ 2.92 $ 2.92    
Weighted Average Remaining Contractual Life, Outstanding at beginning 7 years 10 months 24 days 9 years      
Number of Shares, Grant (in Shares)   28,350,160  
Weighted Average Exercise Price, Grant   $ 6.28  
Weighted Average Grant Date Fair Value, Grant   $ 3.09  
Number of Shares, Forfeited (in Shares) (72,135) (913,710) (1,234,310) (1,190,696) (1,231,675)
Weighted Average Exercise Price, Forfeited $ 6.28 $ 6.28 $ 6.28 $ 3.89 $ 5.83
Weighted Average Grant Date Fair Value, Forfeited $ 4.92 $ 2.97 $ 3.2 $ 2.04 $ 2.27
Number of Shares, Outstanding at ending (in Shares) 33,431,522 33,824,257 33,503,657 34,737,967  
Weighted Average Exercise Price, Outstanding at ending $ 6.18 $ 6.19 $ 6.19 $ 6.19  
Weighted Average Grant Date Fair Value, Outstanding at ending $ 4.98 $ 2.92 $ 4.95 $ 2.92  
Weighted Average Remaining Contractual Life, Outstanding at ending 7 years 8 months 12 days 8 years 8 months 12 days      
Number of Shares, Expected to vest and exercisable (in Shares) 33,431,522 33,824,257 33,503,657 34,737,967 7,578,503
Weighted Average Exercise Price, Expected to vest and exercisable $ 6.18 $ 6.19      
Weighted Average Grant Date Fair Value, Expected to vest and exercisable $ 4.98 $ 2.92 $ 4.95 [1] $ 2.92 $ 2.14
Weighted Average Remaining Contractual Life, Expected to vest and exercisable 7 years 8 months 12 days 8 years 8 months 12 days      
[1] The amount represented weighted average modification date value per share.